• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

MDR-1339 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5764284

MDR-1339 (DWK-1339) is an orally active and blood-brain-barrier-permeable inhibitor of amyloid-beta (Abeta) aggregation. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
MDR-1339, Inhibitor
Full Product Name
MDR-1339
Product Gene Name
Product Synonym Names
DWK-1339
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
326.39
Solubility
DMSO: 80mg/mL (245.11mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C20H22O4
SMILES
COCCCc(cc1)cc2c1oc(-c(cc1)cc(OC)c1OC)c2
CAS Number
1018946-38-7

Product References and Citations for MDR-1339, inhibitor

Ha HJ, et al. Discovery of an Orally Bioavailable Benzofuran Analogue That Serves as a beta-Amyloid Aggregation Inhibitor for the Potential treatment,of Alzheimer's Disease. J Med Chem. 2018 Jan 11;61(1):396-402.

Other Notes

Small volumes of MDR-1339, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for MDR-1339 purchase

MBS5764284 is an inhibitor targeting MDR-1339.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000